Pharmaceutical Lipid-Based Excipients Market 2025 – Strategic Insights for Manufacturing Expansion

 Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

What is the anticipated market size of the pharmaceutical lipid-based excipients industry over the next few years?
The pharmaceutical lipid-based excipients market size has grown strongly in recent years. It will grow from $1.69 billion in 2024 to $1.79 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to rise in prevalence of poorly water-soluble drugs, increase in demand for controlled and targeted drug release, growth in pharmaceutical investments, expand in use of oral solid dosage forms, heightened focus on improving drug bioavailability, and regulatory acceptance of lipid excipients in novel formulations.

The pharmaceutical lipid-based excipients market size is expected to see strong growth in the next few years. It will grow to $2.22 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to rising demand for advanced drug delivery systems, increasing adoption of mRNA and gene therapies, expanding pipeline of poorly water-soluble drugs, growing focus on personalized medicine, supportive regulatory frameworks, and strategic investments in biopharmaceutical manufacturing infrastructure. Major trends in the forecast period include innovations in lipid nanoparticle delivery systems, adoption of mRNA and gene therapies, improved solubility solutions for poorly water-soluble drugs, expansion of biocompatible and sustainable lipid sources, enhanced manufacturing scalability, and adoption in oral and injectable formulations.

Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24374&type=smp

What emerging drivers are expected to shape the future of the pharmaceutical lipid-based excipients market?
The rise in gene therapy is expected to propel the growth of the pharmaceutical lipid-based excipients market going forward. Gene therapy is a medical technique that involves modifying or manipulating a person's genes to treat or prevent disease. The rise in gene therapy is due to advancements in delivery systems, as they enable safe, efficient, and targeted transport of genetic material into cells. Pharmaceutical lipid-based excipients enhance gene therapy by enabling efficient delivery systems, ensuring stability and targeted transport of genetic material. They improve therapeutic outcomes by protecting nucleic acids and facilitating cellular uptake, advancing the effectiveness of modern treatments. For instance, in December 2024, according to American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, the Food and Drug Administration (FDA) approved six gene therapy products in 2023, up from five approvals in 2022. Therefore, the rise in gene therapy is driving the growth of the pharmaceutical lipid-based excipients market.

What emerging segments are shaping the future landscape of the pharmaceutical lipid-based excipients industry?
The pharmaceutical lipid-based excipients market covered in this report is segmented –

1) By Excipient Type: Oils, Hydrogenated Vegetable Oils, GMCC, Hard Fats, Medium Chain Triglycerides, Lecithin And Phospholipids, Sodium Oleate, Capri Caprylic Mono Diglyceride, Other Excipient Types
2) By Product Applications: Oral Formulations, Parenteral, Topical Applications, Ophthalmic Applications, Suppositories, Other Product Applications
3) By Disease Application: Cardiovascular Diseases, Neurological Disorders, Oncology, Metabolic Disorders, Hormonal Therapies, Infectious Diseases, Other Disease Applications
4) By Age Group: Pediatric Products (0-18 years), Adult Products (19-64 years), Geriatric Products (65+ years)
5) By End-Use: Pharmaceutical Manufacturers, Contract Development And Manufacturing Organizations, Other End Users

Subsegments:
1) By Oils: Soybean Oil, Olive Oil, Palm Oil, Sunflower Oil, Other Oils
2) By Hydrogenated Vegetable Oils: Hydrogenated Soybean Oil, Hydrogenated Palm Oil, Hydrogenated Cottonseed Oil, Other Hydrogenated Vegetable Oils
3) By GMCC (Glyceryl Mono/Diesters of C16/C18): Glyceryl Monostearate, Glyceryl Distearate, Glyceryl Monopalmitate, Other GMCC
4) By Hard Fats: Hydrogenated Castor Oil, Hydrogenated Palm Kernel Oil, Hydrogenated Coconut Oil, Other Hard Fats
5) By Medium Chain Triglycerides (MCTs): Capric Triglycerides, Caprylic Triglycerides, Caprylic-Capric Triglycerides, Other MCTs
6) By Lecithin and Phospholipids: Soy Lecithin, Egg Lecithin, Phosphatidylcholine, Phosphatidylserine, Other Lecithin and Phospholipids
7) By Sodium Oleate: Pharmaceutical Grade Sodium Oleate, Food Grade Sodium Oleate, Industrial Grade Sodium Oleate
8) By Capri-Caprylic Mono/Diglycerides: Capric-Caprylic Monoglycerides, Capric-Caprylic Diglycerides
9) By Other Excipient Types: Sucrose Esters, Fatty Acid Esters, PEGylated Lipids, Other Miscellaneous Lipids

View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/pharmaceutical-lipid-based-excipients-global-market-report

What are the key trends shaping the pharmaceutical lipid-based excipients market in the forecast period?
Major companies operating in the pharmaceutical lipid-based excipients market are focusing on investments such as a strategic investment to develop an advanced Center of Excellence to drive innovation, enhance formulation capabilities, support drug delivery research, and strengthen their competitive position in emerging therapeutic areas. For instance, in November 2024, Gattefossé SAS, a France-based chemical manufacturing company, opened a cutting-edge Technical Center of Excellence in Mumbai to support India's growing pharma market, offering specialized labs and tailored support for excipient innovation, with a focus on bioavailability, sustained release, and topical formulations, while strengthening its presence in the Asia-Pacific region. The state-of-the-art facility encompasses pharmaceutical and personal care application laboratories to foster innovation, encourage collaboration, and provide a productive work environment.

How are key players in the pharmaceutical lipid-based excipients market strengthening their market position?
Major companies operating in the pharmaceutical lipid-based excipients market are Cargill Incorporated, BASF SE, Merck KGaA, FUJIFILM Corporation, Evonik Industries AG, DuPont de Nemours Inc., Stepan Company, Croda International, Ashland Corporation, NOF CORPORATION, CordenPharma, SEPPIC, Nippon Fine Chemical Co. Ltd., Cayman Chemical, ABITEC Corporation, Creative Biolabs, IOI Oleo GmbH, Lipoid, RuixiBiotechCo.Ltd, Biosynth

Which geographic areas are contributing significantly to the growth of the pharmaceutical lipid-based excipients sector?
Europe was the largest region in the pharmaceutical lipid-based excipients market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical lipid-based excipients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Can Companies Use The Pharmaceutical Lipid-Based Excipients Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.

Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/customise?id=24374&type=smp

Need Customized Data On Pharmaceutical Lipid-Based Excipients Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you're entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.

Request Customized Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24374&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info


Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Ammonia Market Forecast 2025 – Industry Trends, Challenges & Strategic Intelligence

 For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034. How has the ammonia grown historically, and what trends indicate future expansion? The ammonia market size has grown strongly in recent years. It will grow from $79.13 billion in 2024 to $85.57 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to agricultural demand, expanding population, energy and power generation, chemical manufacturing:. The ammonia market size is expected to see strong growth in the next few years. It will grow to $124.86 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to hydrogen economy development, renewable energy, carbon capture and storage (ccs), clean energy transition. Major trends in the forecast period includ...
Read more

Poultry Disinfectant Market Outlook 2025 – Global Demand, Trends & Forecast

 For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034. What is the forecasted revenue size of the poultry disinfectant industry by 2029? The poultry disinfectant market size has grown strongly in recent years. It will grow from $4.67 billion in 2024 to $5.1 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to demand for biosecurity and disease prevention, growth in poultry farming and agriculture, expansion of food safety regulations, use in hatcheries and broiler farms, regulatory standards for poultry hygiene. The poultry disinfectant market size is expected to see rapid growth in the next few years. It will grow to $7.78 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to sustainable and eco-frie...
Read more

Ammonium Sulfate Market Outlook 2025–2034 – Forecast, Trends & Growth Strategies

 This report is designed for companies and decision-makers seeking actionable insights on market size, growth, trends, and competitive strategies to drive expansion and success in the Ammonium Sulfate industry. What is the projected value of the ammonium sulfate market by 2029? The ammonium sulfate market size has grown strongly in recent years. It will grow from $3.88 billion in 2024 to $4.19 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to economic growth, agriculture demand, government subsidies, population growth, rise in chemical industry. The ammonium sulfate market size is expected to see strong growth in the next few years. It will grow to $6.1 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to increasing crop yields, environmental regulations, food security concerns, rising pharmaceuticals sector, rise in disposable income. Major ...
Read more